{
    "2020-09-14": [
        [
            {
                "time": "2018-09-14",
                "original_text": "格隆汇港股聚焦(9.14)︱京东数科9月10日向上交所提交上市申请；三生制药贝伐珠单抗生物类似药中国IND获受理",
                "features": {
                    "keywords": [
                        "京东数科",
                        "上市申请",
                        "三生制药",
                        "贝伐珠单抗",
                        "IND受理"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-09-15",
                "original_text": "A股头条之上市公司（9.15）",
                "features": {
                    "keywords": [
                        "A股",
                        "上市公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-14",
                "original_text": "9月14日晚间上市公司十大重磅公告",
                "features": {
                    "keywords": [
                        "上市公司",
                        "公告"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-14",
                "original_text": "研发日报丨礼来REYVOW治疗偏头痛2期临床结果积极",
                "features": {
                    "keywords": [
                        "礼来",
                        "REYVOW",
                        "偏头痛",
                        "临床结果"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-09-14",
                "original_text": "港股复盘：继续没有量的上涨",
                "features": {
                    "keywords": [
                        "港股",
                        "复盘",
                        "上涨"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-14",
                "original_text": "华润、上药2大品种通过一致性评价",
                "features": {
                    "keywords": [
                        "华润",
                        "上药",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-09-14",
                "original_text": "上海医药：盐酸克林霉素胶囊通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "上海医药",
                        "盐酸克林霉素",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-09-14",
                "original_text": "上海医药(601607.SH)：盐酸克林霉素胶囊通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "上海医药",
                        "盐酸克林霉素",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-09-14",
                "original_text": "上海医药(02607.HK)遭全国社会保障基金理事会减持173.65万股 减持股份",
                "features": {
                    "keywords": [
                        "上海医药",
                        "社保基金",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-14",
                "original_text": "智通港股早知道|(9月14日)金融控股公司监督管理办法落地，留意招商局集团系列等股价波动",
                "features": {
                    "keywords": [
                        "金融控股",
                        "监督管理办法",
                        "招商局集团",
                        "股价波动"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}